Skip to main content
. 2018 Sep 4;12:199. doi: 10.3389/fnbeh.2018.00199

Figure 4.

Figure 4

Thermal pain withdrawal latencies of Meis1KO and D3KO before and after treatment with the D3R antagonist SB 277011. (A) In Meis1KO, SB277 significantly decreased withdrawal latencies. (B) In D3KO, treatment with SB277 did not lead to any significant changes in withdrawal latencies.